Where Leaders in Oncology UniteAgainst Lung Cancer||To Share Knowledge||To Exchange||To Debate||To Advance Care||To Fight Cancer||To Drive Progress||To Provide Insights
CME-certified
Expert-Driven Education & Insights
LATEST
Sessions On Demand
2025 Approvals & Highlights
1 h 49 min
UNLOCKING NEW POTENTIALS IN EGFR-MUTANT NSCLC
30 min
RESHAPING APPROACHES IN SCLC WITH THE LATEST ADVANCES IN LS- AND ES-DISEASE
34 min
LATEST OPTIONS FOR NON-ONCOGENE ADDICTED METASTATIC NSCLC IN FRONTLINE AND BEYOND
32 min
THE ROLE OF IO ADDED TO CHEMORADIATION IN UNRESECTABLE STAGE III NSCLC
28 min
TAILORING IO IN RES. NSCLC: PERSONALIZED APPROACHES FOR IMPROVED OUTCOMES
36 min
Latest Advances in Frontline EGFR+ NSCLC
14 min
THE ADC REVOLUTION IN LUNG CANCER: NEW TARGETS, NEW OPPORTUNITIES
27 min
DEBATE: WHICH IS THE BETTER CHOICE IN EGFR+ METASTATIC NSCLC?
31 min
ACTIONABLE GENOMIC ALTERATIONS – INCLUDING HER2 AND MET
26 min
TARGETING EGFR AND ALK IN NSCLC
26 min
CUTTING-EDGE DIAGNOSTIC TECHNIQUES AND EMERGING BIOMARKERS
24 min
ILCS 2026
International Lung Cancer Summit 2026
ADD THIS TO YOUR CALENDAR
Google Calendar (Online)
Outlook Calendar (Offline)-
Outlook On Microsoft Office 365 (Online) -
Outlook On The Web (Online) 
Apple Offline Calendar / iCal
When: 9:45 AM - 4:45 PM (CET)
Following the success of the previous International Lung Cancer Summits (ILCS), we warmly invite you to the 8th edition, expertly chaired by the distinguished duo Solange Peters and Alfredo Addeo. This premier hybrid conference continues its tradition of excellence by highlighting the latest breakthroughs in lung cancer treatment. With a global lineup of renowned speakers from the USA, Japan, France, Portugal, Italy, Ireland, Greece, and the Netherlands, the ILCS provides a unique platform for professionals from clinics, universities, and research institutes to engage, network, and collaborate. By leveraging digital platforms, the summit fosters a dynamic environment for sharing insights and advancing lung cancer care.
LED BY GLOBAL EXPERTS
Umberto Malapelle
Italy
Hidehito Horinouchi
Japan
Telma Sequeira
Portugal
Christine Lovly
USA
David Planchard
France
Sandip Patel
USA
Jarushka Naidoo
Ireland
Giannis Mountzios
Greece
Anne-Marie Dingemans
Netherlands
ADD THIS TO YOUR CALENDAR
- Google Calendar (Online)
- Outlook Calendar (Offline)
- Outlook On Microsoft Office 365 (Online)
- Outlook On The Web (Online)
- Apple Offline Calendar / iCal
When: 9:45 AM - 4:30 PM (CET)
CHECK OUT OUR PROGRAM
13th November 2026
All times are in Central European Time
9.45
Welcome & Introduction by Chairs
Solange Peters & Alfredo Addeo
9.50
EMERGING BIOMARKERS AND LIQUID BIOPSIES
Umberto Malapelle (Italy)
10.10
NEW STANDARDS IN EGFR- AND ALK-POSITIVE NSCLC
Hidehito Horinouchi (Japan)
10.35
HER2 AS A NEW ACTIONABLE GENOMIC ALTERATION
Telma Sequeira (Portugal)
11.00
Open Discussion & Coffee Break
11.20
TARGETING (K)RAS WITH NEW COMPOUNDS
Christine Lovly (USA)
11.50
THE ADC WAVE: INTEGRATING NEW AGENTS INTO THE STANDARD OF CARE
David Planchard (France)
12.30
INDUSTRY SATELLITE SYMPOSIA
14.15
LATEST OPTIONS IN EARLY STAGE NSCLC: NOVEL IO APPROACHES FOR IMPROVED OUTCOMES
Sandip Patel (USA)
14.40
NEW COMPOUNDS AND COMBINATIONS FOR NON-ONCOGENE ADDICTED METASTATIC NSCLC
Jarushka Naidoo (Ireland)
15.10
Open Discussion & Coffee Break
15.30
THE EMERGING ROLE OF T-CELL ENGAGERS
15.50
DEBATE: WHICH IS THE BETTER CHOICE IN 1L ES-SCLC?
-
ARGUING FOR IMMUNOTHERAPY + CHEMO / LURBINECTEDIN
Giannis Mountzios (Greece)
-
ARGUING FOR IMMUNOTHERAPY + DLL3 T-CELL ENGAGERS
Anne-Marie Dingemans (Netherlands)
16.20
PANEL DISCUSSION: OPEN QUESTIONS & PATIENT CASES BY AUDIENCE
All Speakers & Attendees
16.45
Closing Remarks by Chairs
Solange Peters & Alfredo Addeo
THE ILCS IS INTERNATIONALLY ACCREDITED WITH 5 CME CREDITS, EACH BY:
- EUROPEAN ACCREDITATION COUNCIL FOR CME (EACCME)
- SWISS SOCIETY OF MEDICAL ONCOLOGY
EACCME credits can be converted to AMA PRA Cat. 1 Credits.
